Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Fierce Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Fierce Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 175 · Grade C

Fierce Health

Visit Fierce Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 69 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Fierce Health a bad call — it's best for readers who want lifestyle support alongside clinical care and can confirm the available plan and controlling prescription terms. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
46
Supply Reliability
95
70
Transparency
90
88
Access Breadth
93
80
Clinical Oversight
92
74
Track Record
88
60
CoreAge RxBrief Score 94 · 69Fierce Health

Price, coverage & the tracker

CoreAge RxFierce Health
Brief Score94/100 (A)69/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm selected plan

Monthly selection lists $199; confirm availability, supplied quantity and complete charge. Separate prepaid and microdose choices have different terms.

Full price details

Compounded semaglutide offered; complete current plan and availability quote unknown; monthly selection lists $199; earlier listing: From $297/mo (3-month plan, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm formulation and plan

Monthly selection lists $299; exact formulation, supply and availability need confirmation. An enabled purchase button is not prescription approval.

Full price details

Current tirzepatide formulation and complete quote unknown; monthly selection lists $299; earlier listing: From $497/mo (3-month plan, compounded)

CoverageUS only; restrictions by state, confirmed at intakeProduct pages advertise all 50 states, but terms list a narrower service area; confirm your location and treatment
Brand-name accessNot confirmedCurrent branded-medication program unconfirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Fierce Health: Monthly listings show $199 semaglutide/$299 tirzepatide, with conflicting availability messages. Confirm the selected medication, supply and complete charge before paying.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.